DalsnaFinance Account

HCA Healthcare $HCA

Health Care · Health Care Facilities · NYSE/NASDAQ

S&P 500 Russell 1000 Tennessee

Create a scorecard

$462.24

+7.36 (+1.62%)

As of Oct 20, 2026, 12:08 PM EDT · cached

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Jul 27, 2026, the first target we tracked for HCA.

Key facts

52-week range (closes): $361.32 – $545.13 Lowest close Jun 8, 2026, highest Mar 9, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Next earnings: Oct 27, 2026, before the open · EPS forecast $6.75 Nasdaq earnings calendar, as of Oct 20, 2026
Fiscal year ends: December Fiscal 2025 ended Dec 31, 2025, from SEC filings
In the S&P 500 since: Jan 27, 2015, replacing Safeway (SWY) and Covidien (COV) · Safeway was acquired by a private equity consortium. · Covidien was acquired by Medtronic. · All S&P 500 changes
Analyst coverage: 1 open price target from 1 firm: KeyBanc Capital Markets Approved targets tracked here; see the analyst section below

HCA Healthcare (HCA) is trading up at $462.24 (+1.62%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on HCA

One firm's current price target on HCA Healthcare: $435 — 6% below the current $462. Each is tracked to its date and scored the same way a member's call is.

KeyBanc Capital Markets $390 → $435 by Jul 2027 Overweight Jul 27, 2026 via Investing.com · KeyBanc Capital Markets's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

HCA Healthcare revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

HCA Healthcare annual financial statements
	FY2016Dec 2016	FY2017Dec 2017	FY2018Dec 2018	FY2019Dec 2019	FY2020Dec 2020	FY2021Dec 2021	FY2022Dec 2022	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$41.5B	$43.6B	$46.7B	$51.3B	$51.5B	$58.8B	$60.2B	$65.0B	$70.6B	$75.6B
Growth (year over year)	—	+5.1%	+7.0%	+10.0%	+0.4%	+14.0%	+2.5%	+7.9%	+8.7%	+7.1%
Net income	$2.89B	$2.22B	$3.79B	$3.50B	$3.75B	$6.96B	$5.64B	$5.24B	$5.76B	$6.78B
Net margin	7.0%	5.1%	8.1%	6.8%	7.3%	11.8%	9.4%	8.1%	8.2%	9.0%
EPS (diluted)	$7.30	$5.95	$10.66	$10.07	$10.93	$21.16	$19.15	$18.97	$22.00	$28.33
Balance sheet
Cash and equivalents	$646.0M	$732.0M	$502.0M	$621.0M	$1.79B	$1.45B	$908.0M	$935.0M	$1.93B	$1.04B
Total assets	$33.8B	$36.6B	$39.2B	$45.1B	$47.5B	$50.7B	$52.4B	$56.2B	$59.5B	$60.7B
Total liabilities	$39.4B	$41.6B	$42.1B	$45.6B	$44.6B	$49.3B	$52.5B	$55.2B	$59.0B	$63.5B
Long-term debt	$31.2B	$32.9B	$32.0B	$33.6B	$30.8B	$34.3B	$37.7B	$37.2B	$38.3B	$41.6B
Shareholders' equity	−$7.30B	−$6.81B	−$4.95B	−$2.81B	$572.0M	−$933.0M	−$2.77B	−$1.77B	−$2.50B	−$6.03B
Cash flow
Operating cash flow	$5.65B	$5.43B	$6.76B	$7.60B	$9.23B	$8.96B	$8.52B	$9.43B	$10.5B	$12.6B
Capital expenditure	$2.76B	$3.02B	$3.57B	$4.16B	$2.83B	$3.58B	$4.39B	$4.74B	$4.88B	$4.94B
Free cash flow	$2.89B	$2.41B	$3.19B	$3.44B	$6.40B	$5.38B	$4.13B	$4.69B	$5.64B	$7.69B
Dividends paid	—	$0	$487.0M	$550.0M	$153.0M	$624.0M	$653.0M	$661.0M	$690.0M	$679.0M
Share buybacks	$2.75B	$2.05B	$1.53B	$1.03B	$441.0M	$8.21B	$7.00B	$3.81B	$6.04B	$10.1B

RevenueNet incomeNet margin (right axis, %)

HCA Healthcare quarterly financial statements
	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24^†Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25^†Dec 2025	Q1 FY26Mar 2026
Income statement
Revenue	$17.5B	$17.5B	$18.3B	$18.3B	$18.6B	$19.2B	$19.5B	$19.1B
Growth (year over year)	+10.3%	+7.9%	+5.7%	+5.7%	+6.4%	+9.6%	+6.7%	+4.3%
Net income	$1.46B	$1.27B	$1.44B	$1.61B	$1.65B	$1.64B	$1.88B	$1.62B
Net margin	8.4%	7.3%	7.9%	8.8%	8.9%	8.6%	9.6%	8.5%
EPS (diluted)	$5.53	$4.88	$5.66	$6.45	$6.83	$6.96	$8.09	$7.15
Balance sheet
Cash and equivalents	$831.0M	$2.89B	$1.93B	$1.06B	$939.0M	$997.0M	$1.04B	$940.0M
Total assets	$57.4B	$59.5B	$59.5B	$59.8B	$59.5B	$59.7B	$60.7B	$61.5B
Total liabilities	$56.0B	$58.7B	$59.0B	$60.2B	$60.8B	$61.9B	$63.5B	$64.4B
Long-term debt	$36.3B	$38.3B	$38.3B	$41.1B	$39.4B	$38.4B	$41.6B	$39.5B
Shareholders' equity	−$1.60B	−$2.18B	−$2.50B	−$3.52B	−$4.39B	−$5.33B	−$6.03B	−$6.30B
Cash flow
Operating cash flow	$1.97B	$3.52B	$2.56B	$1.65B	$4.21B	$4.42B	$2.36B	$2.01B
Capital expenditure	$1.28B	$1.19B	$1.28B	$991.0M	$1.18B	$1.29B	$1.49B	$1.12B
Free cash flow	$690.0M	$2.32B	$1.27B	$660.0M	$3.03B	$3.13B	$870.0M	$895.0M
Dividends paid	$171.0M	$169.0M	$165.0M	$180.0M	$171.0M	$166.0M	$162.0M	$183.0M
Share buybacks	$1.37B	$1.79B	$1.70B	$2.51B	$2.50B	$2.50B	$2.56B	$1.57B

From HCA Healthcare's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

HCA Healthcare vs the Health Care sector and the S&P 500

HCA Healthcare's latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

HCA Healthcare compared with the median Health Care company and the median S&P 500 company
Measure	HCA Healthcare	Health Care (59 other S&P 500 companies)	S&P 500 (502 other companies)
Revenue growth, latest fiscal year	+7.1%	+7.2%	+7.0%
Net margin, latest fiscal year	9.0%	13.1%	13.0%
Dividend per share, latest fiscal year	$2.88	$2.43	$2.40
Share price change, 1 year	+5.0%	+19.8%	+5.9%

HCA Healthcare: fiscal year ended December 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, HCA Healthcare included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, dividend per share 32/349, 1-year price change 59/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them; dividend medians are among the 32 sector and 349 S&P 500 companies reporting a per-share dividend. The S&P 500 price figure is the middle company's change, not the index's return.

About HCA Healthcare

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

Source: Wikipedia — HCA Healthcare